General Information
Drug ID
DR00715
Drug Name
Sulindac
Synonyms
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid; (Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid; 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid; 5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid; Aclin; Aflodac; Alphapharm Brand of Sulindac; Apo Sulin; Apo-Sulin; Apotex Brand of Sulindac; Arthrobid; Arthrocine; Cahill May Roberts Brand of Sulindac; Chemia Brand of Sulindac; Chibret; Cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid; Cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid; Clinoril; Clinoril (TN); Copal; Copal resin; Copal rosin varnish; Copals; Gum copal; Kenalin; KendrickBrand of Sulindac; Klinoril; MK 231; MK-231; MK231; Merck Brand of Sulindac; Merck Sharp & Dohme Brand of Sulindac; Mobilin; Novo Sundac; Novo-Sundac; Novopharm Brand of Sulindac; Nu Pharm Brand of Sulindac; Nu Sulindac; Nu-Pharm Brand of Sulindac; Nu-Sulindac; Resin copal; S 8139; Sulindac (JAN/USP/INN); Sulindac [USAN:BAN:INN:JAN]; Sulindac sulfoxide; Sulindaco; Sulindaco [INN-Spanish]; Sulindacum; Sulindacum [INN-Latin]; Sulindal; Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid; [(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid; {(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid; {5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
Drug Type
Small molecular drug
Indication Rheumatoid arthritis [ICD11: FA20] Approved [1]
Therapeutic Class
Antiinflammatory Agents
Structure
3D MOL 2D MOL
Formula
C20H17FO3S
Canonical SMILES
CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
InChI
InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-
InChIKey
MLKXDPUZXIRXEP-MFOYZWKCSA-N
CAS Number
CAS 38194-50-2
Pharmaceutical Properties Molecular Weight 356.4 Topological Polar Surface Area 73.6
Heavy Atom Count 25 Rotatable Bond Count 4
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 5
XLogP
3.4
PubChem CID
1548887
PubChem SID
103179013 , 103925149 , 104170038 , 104253449 , 110524953 , 11111823 , 11111824 , 11114189 , 11534177 , 118307514 , 121361866 , 121362536 , 14828051 , 17405626 , 26611935 , 26680385 , 26732639 , 26747172 , 26747173 , 32248851 , 46506570 , 4693 , 47216762 , 47736459 , 47959726 , 47959727 , 47959728 , 48035101 , 48035102 , 48259216 , 49699049 , 49982642 , 50106970 , 50106971 , 53778176 , 53789046 , 57409048 , 75972879 , 7847188 , 7980709 , 8149543 , 85231236 , 85787894 , 8653294 , 90341400 , 91011398 , 92124295 , 92303413 , 92307725 , 99301689
ChEBI ID
ChEBI:9352
TTD Drug ID
D0Z5IU
DT(s) Transporting This Drug MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [2]
References
1 Sulindac was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J Neurochem. 2010 Oct;115(1):200-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.